---
title: "GDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain high"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295009416.md"
description: "Revenue and net income declined year-over-year as the business shifts focus to Pharma Direct and subscriptions, which are growing but currently pressure overall results. Legal and market risks remain elevated, with significant litigation accruals and ongoing industry changes impacting performance.Original document: GoodRx Holdings, Inc. [GDRX] SEC 10-Q Quarterly Report — Aug. 6 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T20:21:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295009416.md)
  - [en](https://longbridge.com/en/news/295009416.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295009416.md)
generator: "portal-rs"
---

# GDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain high

Revenue and net income declined year-over-year as the business shifts focus to Pharma Direct and subscriptions, which are growing but currently pressure overall results. Legal and market risks remain elevated, with significant litigation accruals and ongoing industry changes impacting performance.

Original document: GoodRx Holdings, Inc. \[GDRX\] SEC 10-Q Quarterly Report — Aug. 6 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [GDRX.US](https://longbridge.com/en/quote/GDRX.US.md)

## Related News & Research

- [Francisco Partners IV, L.P. reports disposal of 1,193,951 GoodRx common shares for $4.2 million](https://longbridge.com/en/news/296661857.md)
- [GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen](https://longbridge.com/en/news/295992826.md)
- [GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages](https://longbridge.com/en/news/295890730.md)
- [09:00 ETPaytient Expands into Prescription Benefits to Help Employers and Employees Combat Rising Drug Costs](https://longbridge.com/en/news/292492405.md)
- [GoodRx Q2 net income falls 34% to $8.5 million; revenue slips 1% to $200.4 million](https://longbridge.com/en/news/295013649.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**